Colin John Meyer, Chief Innovation Officer at REATA PHARMACEUTICALS INC (RETA), sold 12,466 shares at $80.94 ($1.1M) on 2023-05-16, disclosed to the SEC on 2023-05-17.
Open-market sale of $1.1M RETA by Chief Innovation Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.76 | 4,469 | $379K | 35.9% |
| 2 | $84.76 | 4,469 | $379K | 35.9% |
| 3 | $85.77 | 1,139 | $98K | 9.3% |
| 4 | $85.77 | 1,139 | $98K | 9.3% |
| 5 | $80.94 | 625 | $51K | 4.8% |
| 6 | $80.94 | 625 |
| $51K |
| 4.8% |
| Total | $84.56 avg | 12,466 | $1.1M | 100% |
| Filing → |
| RETA | SELL | 2023-03-06 | $16.3M | — | Filing → |
| RETA | SELL | 2021-06-16 | $16.4M | — | Filing → |
| RETA | SELL | 2020-11-18 | $8.0M | — | Filing → |